Medicare & Billing

Assignment of Benefit Update: The 12-Month Reprieve and Enduring Assignment of Benefit

Medicare & Billing /

In June 2026, after sustained advocacy from the RACGP and AMA, the Government softened its assignment of benefit (AoB) reforms. From 1 July 2026, verbal consent will still be accepted in all settings for a 12-month transition, and an enduring AoB option opens for MyMedicare-registered patients, aged care residents, and ACCHO/AMS patients. This article sets out what actually changes on 1 July, and how to record an enduring AoB for your MyMedicare patients.

Assignment of Benefit Update: The 12-Month Reprieve and Enduring Assignment of Benefit Read More »

Budget Update: What the 2026-27 Strengthening Medicare Package Means for GPs

Medicare & Billing /

The Strengthening Medicare 2026-27 Federal Budget commits $11.4 billion to bulk billing incentives and $5.9 billion to new PBS listings, alongside a new Medicare-funded three-year-old health check, a two-year extension of the PIP Quality Improvement Incentive, and an Extended Medicare Safety Net cap that has drawn RACGP concern. Here is what matters for general practice.

Budget Update: What the 2026-27 Strengthening Medicare Package Means for GPs Read More »

My Health Record Sharing-by-Default Starts 1 July 2026: What It Means for Your Practice

Medicare & Billing /

From 1 July 2026, pathology and diagnostic imaging providers must upload reports to My Health Record (MyHR) by default. The reform is part of the Government’s “Better and Faster Access to health information” program, and it changes both what flows into MyHR and how quickly patients can see it. For GPs, this means more results available faster, a shorter delay on sensitive results, and a new compliance dimension for any practice that operates its own pathology collection or imaging service.

My Health Record Sharing-by-Default Starts 1 July 2026: What It Means for Your Practice Read More »

Assignment of Benefit Changes from 1 July 2026: What Every GP Practice Should Set Up

Medicare & Billing /

From 1 July 2026, the way practices collect a patient’s assignment of Medicare benefit (AoB) for bulk-billed and simplified-billing services changes substantially. Paper-based, in-consultation co-signing is replaced by digital consent options, the practitioner co-signature requirement is removed, and a new two-year record-retention rule applies. This article sets out what every GP and practice manager needs to have in place before the deadline.

Assignment of Benefit Changes from 1 July 2026: What Every GP Practice Should Set Up Read More »

Bulk-Billing Income & Workload Calculator for Australian GPs

Medicare & Billing /

Disclaimer: This calculator provides estimates for educational purposes only based on standard MBS schedule fees current as of May 1, 2026. It does not account for taxation, superannuation, business expenses, registrar service-fee arrangements, non-standard billing patterns, or individual practice circumstances. It is not financial, accounting, or taxation advice. Confirm current rebates at MBS Online and

Bulk-Billing Income & Workload Calculator for Australian GPs Read More »

The National Medicines Record: What the 2026 Reforms Mean for Australian GPs

Medicare & Billing /

Recent federal reforms mark a significant shift in Australian digital health governance with the introduction of a National Medicines Record (NMR). This guide explores how mandatory reporting will centralise prescribing data, mitigate risks from fragmented telehealth services, and enhance clinical oversight for General Practitioners.

The National Medicines Record: What the 2026 Reforms Mean for Australian GPs Read More »

PBS Update: Semaglutide (Wegovy) Recommended for Cardiovascular Risk in Obesity

Medicare & Billing /

The PBAC has recommended the PBS listing of semaglutide 2.4 mg for patients with established cardiovascular disease and severe obesity. This article outlines the specific eligibility criteria, including BMI thresholds and ethnicity adjustments, and examines the administrative implications for Australian general practice.

PBS Update: Semaglutide (Wegovy) Recommended for Cardiovascular Risk in Obesity Read More »

Join Our Community

Register to our newsletter delivered on a regular basis!